0
Home
News
Directory
E-newsletter
Magazine
Events
Data
AgReport
Subscribe
Syngenta invests in U.S. biotech company Metabolon
Oct. 28, 2009
Related News
Syngenta Ventures, the venture capital unit of agribusiness company Syngenta AG, said Tuesday it is investing an undisclosed amount in privately held biotechnology company Metabolon.
Metabolomics develops technology sued to accelerate the development of plants.
Syngenta Ventures will take a seat on Metabolons board of directors. It said the equity investment was made in the Series C financing of Metabolon which raised $12.3 million from a several investors, including Syngenta Ventures.
Syngenta is headquartered in Switzerland. American Depository Shares fell 62 cents to $48.47 in afternoon trading.
Source: Yahoo news
More from AgroNews
Change
Hot TopicSubscribe
| Subscribe Email: | * | |
| Name: | ||
| Mobile Number: | ||
Comment
0/1200
NEWSLETTER